MARKET

BLCO

BLCO

Bausch + Lomb Corporation
NYSE
16.81
-0.15
-0.88%
After Hours: 16.81 0 0.00% 16:00 12/04 EST
OPEN
16.80
PREV CLOSE
16.96
HIGH
17.15
LOW
16.80
VOLUME
172.00K
TURNOVER
--
52 WEEK HIGH
20.71
52 WEEK LOW
10.45
MARKET CAP
5.95B
P/E (TTM)
-19.4605
1D
5D
1M
3M
1Y
5Y
1D
Cooper Cos. jumps after starting strategic review, naming new board chair
Seeking Alpha · 8h ago
Balanced Hold Rating on Bausch + Lomb Amid Strategic Updates and Long-term Uncertainties
TipRanks · 19h ago
Bausch + Lomb’s CVS pact ending probably a good thing, says Morgan Stanley
TipRanks · 1d ago
Bausch + Lomb (BLCO) Is Up 7.3% After Morgan Stanley Highlights Disruptive Ophthalmology Pipeline
Simply Wall St · 1d ago
Morgan Stanley Upgrades Bausch & Lomb to Overweight, Raises Price Target to $21
Benzinga · 2d ago
Bausch + Lomb upgraded at Morgan Stanley on pipeline
Seeking Alpha · 2d ago
Bausch + Lomb upgraded to Overweight at Morgan Stanley on pipeline potential
TipRanks · 2d ago
Bausch + Lomb upgraded to Overweight from Equal Weight at Morgan Stanley
TipRanks · 2d ago
More
About BLCO
Bausch + Lomb Corporation is an eye health company. It operates through three segments: Vision Care, Pharmaceuticals, and Surgical. Vision Care segment includes both a contact lens and a consumer eye care business that consists of contact lens care products, over-the-counter eye drops and eye vitamins. Pharmaceuticals segment consists of generic pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. Surgical segment consists of medical device equipment, consumables, instruments and technologies for the treatment of cataracts, corneal and vitreous and retinal eye conditions, which includes delivery systems, phacoemulsification equipment and other surgical instruments and devices for cataract surgery. Its brands consist of PreserVision, Biotrue, Artelac, Alaway, Mioclear, Ocuvite, ScoutPro, XIIDRA, Vyzulta, Lotemax, Prolensa, Minims, INFUSE, and many more.

Webull offers Bausch + Lomb Corp stock information, including NYSE: BLCO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BLCO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BLCO stock methods without spending real money on the virtual paper trading platform.